Global surgical site infection market is forecasted to reach $5.9 billion by 2023. The market growth can be attributed to the development of technologically advanced products and growing geriatric population. Furthermore, increasing number of surgical procedures and rising incidence of SSIs are boosting the market growth. Explore report at: https://www.psmarketresearch.com/market-analysis/surgical-site-infection-market Antibiotic prophylaxis products generated the largest revenue in the surgical site infection market in 2017. In most cases, patients’ sensitivity to certain drugs creates the need for specific antibiotics, which, in turn, adds to the treatment cost. Owing to this factor, antibiotic prophylaxis products continue to be in high demand in the market. However, the fastest growth in the market during the forecast period is expected from the antiseptic and disinfectant product category, with a CAGR of 7.4%.
Among all phases, the demand for products for the intraoperative phase is expected to exhibit the fastest growth in the surgical site infection market, at a CAGR of 6.6%, during the forecast period. This can be attributed to the wide usage of SSI preventive products during the intraoperative phase, as the chances of contamination to open wounds are the highest during this phase. Also, due to this reason, healthcare facilities are increasingly complying with the World Health Organization (WHO) guidelines that suggest measures to prevent infections. Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=surgical-site-infection-market
During the forecast period, the surgical site infection market is expected to witness the fastest growth in APAC, at a CAGR of 7.7%. The APAC surgical site infection market is also expected to reach $1,492.8 million by 2023. The market growth in APAC is mainly driven by growing geriatric population, rising incidence of SSIs, increasing adoption of technologically advanced products, and improving healthcare infrastructure. According to the UN publication World Population Ageing 2017, in Asia, the number of people aged 60 years or above is estimated to increase from 549 million in 2017 to nearly 1.3 billion in 2050. Also, there is a high adoption rate of technologically advanced products in Japan. Besides, the country is witnessing an increase in its geriatric population. These factors are expected to continue driving the growth of the surgical site infection market market in Japan.
In order to increase their market share, key players of the surgical site infection industry are entering into partnerships. For instance, in January 2018, Mölnlycke Health Care AB entered into a partnership with Tissue Analytics, a developer of digital wound-imaging platforms. With this partnership, both the companies intend to jointly develop and commercialize innovative digital solutions (such as comprehensive clinical decision support tools) for wound care professionals. Request for Sample Copy at: https://www.psmarketresearch.com/market-analysis/surgical-site-infection-market/report-sample Some of the other key players operating in the surgical site infection market are 3M Company, STERIS plc, Stryker Corporation, Medtronic plc, Prescient Surgical Inc., Covalon Technologies Ltd., Surgical Site Infection Prevention LLC, HARTMANN GROUP, B. Braun Melsungen AG, and Becton, Dickinson and Company.
THANK YOU! For queries, kindly write to: firstname.lastname@example.org GET IN TOUCH www.psmarketresearch.com B-13, Sector-2, Noida, U.P.-201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 US/Canada Toll-Free: 1-888-778-7886